Evidence map›Paper›PMID 33465083›Full record

ArticlePLoS genetics2021

Ciona Brachyury proximal and distal enhancers have different FGF dose-response relationships.

Matthew J Harder, Julie Hix, Wendy M Reeves, Michael T Veeman

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Fine-Tuned Expression of Evolutionarily Conserved Signaling Molecules in theInternational journal of molecular sciences · 2024
    Article
  4. Review
  5. Dynamics ofProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  6. Pak2 reduction induces a failure of early embryonic development in mice.Reproductive biology and endocrinology : RB&E · 2021
    Article
  7. Article
  8. Quantitative Dissection of the ProximalFrontiers in cell and developmental biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Matthew J HarderDivision of Biology, Kansas State University, Manhattan, Kansas, United States of America.
Julie HixDivision of Biology, Kansas State University, Manhattan, Kansas, United States of America.
Wendy M ReevesDivision of Biology, Kansas State University, Manhattan, Kansas, United States of America.ORCID 0000-0001-9584-8896
Michael T VeemanDivision of Biology, Kansas State University, Manhattan, Kansas, United States of America.ORCID 0000-0002-0752-6537
Kansas State University · US

Funding

Morphogenetic effector networks in the Ciona notochordR01HD085909 · NICHD · KANSAS STATE UNIVERSITY · PI VEEMAN, MICHAEL TERRENCE · 2015 to 2019
$1.5M
NICHD NIH HHS R01 HD085909
6 · The paper itself

Abstract

Many genes are regulated by two or more enhancers that drive similar expression patterns. Evolutionary theory suggests that these seemingly redundant enhancers must have functionally important differences. In the simple ascidian chordate Ciona, the transcription factor Brachyury is induced exclusively in the presumptive notochord downstream of lineage specific regulators and FGF-responsive Ets family transcription factors. Here we exploit the ability to finely titrate FGF signaling activity via the MAPK pathway using the MEK inhibitor U0126 to quantify the dependence of transcription driven by different Brachyury reporter constructs on this direct upstream regulator. We find that the more powerful promoter-adjacent proximal enhancer and a weaker distal enhancer have fundamentally different dose-response relationships to MAPK inhibition. The Distal enhancer is more sensitive to MAPK inhibition but shows a less cooperative response, whereas the Proximal enhancer is less sensitive and more cooperative. A longer construct containing both enhancers has a complex dose-response curve that supports the idea that the proximal and distal enhancers are moderately super-additive. We show that the overall expression loss from intermediate doses of U0126 is not only a function of the fraction of cells expressing these reporters, but also involves graded decreases in expression at the single-cell level. Expression of the endogenous gene shows a comparable dose-response relationship to the full length reporter, and we find that different notochord founder cells are differentially sensitive to MAPK inhibition. Together, these results indicate that although the two Brachyury enhancers have qualitatively similar expression patterns, they respond to FGF in quantitatively different ways and act together to drive high levels of Brachyury expression with a characteristic input/output relationship. This indicates that they are fundamentally not equivalent genetic elements.

Indexed as

Amino Acid SequenceAnimalsBrachyury ProteinCiona intestinalisEnhancer Elements, GeneticFetal ProteinsFibroblast Growth FactorsGene Expression Regulation, DevelopmentalMAP Kinase Signaling SystemNotochordPromoter Regions, GeneticT-Box Domain ProteinsTranscription FactorsBrachyury ProteinFetal ProteinsFibroblast Growth FactorsT-Box Domain ProteinsTranscription Factors

Identifiers

PMID33465083
PMCPMC7846015
OpenAlexW3121779177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.